PNC Financial Services Group
EDSA icon

PNC Financial Services Group’s Edesa Biotech EDSA Stock Holding History

PNC Financial Services Group’s Portfolio EDSA Stock Details EDSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5
Closed -$32 – 4766
2023
Q1 		$32 Buy
+5
New +$52 ﹤0.01% 4649

Other funds holding EDSA

VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

PNC Financial Services Group's EDSA Position: Q2 2023 in Review

PNC Financial Services Group sold out of Edesa Biotech (EDSA) in Q2 2023, closing a stake of 5 shares — an estimated $32 sold.

PNC Financial Services Group first reported a position in EDSA in Q1 2023 and held it in 1 quarter. The position peaked at $32 in Q1 2023. 22 funds tracked by Wall St. Rank hold EDSA as of Q2 2023.

  • PNC Financial Services Group reported no remaining Edesa Biotech position as of Q2 2023 after selling out during the quarter.
  • PNC Financial Services Group sold 5 Edesa Biotech shares in Q2 2023, an estimated $32.
  • PNC Financial Services Group first reported a position in Edesa Biotech in Q1 2023 and held it in 1 quarter.
  • PNC Financial Services Group's Edesa Biotech position peaked at $32 in Q1 2023.
  • 22 funds tracked by Wall St. Rank held Edesa Biotech as of Q2 2023.

Based on PNC Financial Services Group's 13F filing for Q2 2023, filed 11 Aug 2023.